US Patent Issued to INNATE PHARMA on Oct. 21 for "Treatment of T cell lymphoma" (French Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,448,442, issued on Oct. 21, was assigned to INNATE PHARMA (Marseilles, France).

"Treatment of T cell lymphoma" was invented by Hatem Abdelazim (Marseilles, France) and Carine Paturel (Marcy l'Etoile, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to methods for the treatment of T cell lymphomas using compounds that specifically bind KIR3DL2 in combination with chemotherapeutic agents, notably gemcitabine and/or oxaliplatin. The treatments are particularly useful in the treatment of peripheral T cell lymphomas, for example PTCL-NOS."

The patent was filed on July 21, 2021, under Application No. 17/381,418.

*For furth...